PPG-based AF detection algorithm / Heart Failure / Atrial Fibrillation (AF) · Observational Study
ClinicalTrials.gov · August 6, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a clinical trial registry record for a prospective validation study of a photoplethysmography-based machine-learning algorithm for atrial fibrillation detection. The study is currently recruiting and has not yet reported results. The planned primary outcome is diagnostic accuracy (area under the ROC curve) compared to 12-lead ECG.
Observational. Atrial Fibrillation (AF), Heart Failure; age from 18 Years. Intervention: Documented AF; Non-AF. Compared with: Gold-standard 12-lead ECG. n = 200. 1 site: Slovakia.
This is a clinical trial registry record for a prospective validation study of a photoplethysmography-based machine-learning algorithm for atrial fibrillation detection. The study is currently recruiting and has not yet reported results. The planned primary outcome is diagnostic accuracy (area under the ROC curve) compared to 12-lead ECG.
Study is still recruiting; no efficacy or safety data are available
This algorithm is in early validation; it is not yet ready for clinical deployment. Clinicians should await published results before considering integration into practice.
This is a prospective validation study still recruiting participants with no results posted; it represents early clinical evaluation of a machine-learning algorithm in development.
As stated by the source record.
Quoted from the source exactly as published.
This algorithm is in early validation; it is not yet ready for clinical deployment. Clinicians should await published results before considering integration into practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07749183). This is a study registration, not published results. Lead sponsor: Seerlinq s. r. o.. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 200 participants (ESTIMATED). Conditions: Atrial Fibrillation (AF), Heart Failure. Interventions: OTHER: PPG-based AF detection algorithm. Primary outcome measures: Diagnostic accuracy (area under the ROC curve) of the PPG-based machine-learning algorithm for detecting clinically relevant AF (≥ 30s), compared with gold-standard 12-lead ECG , Through study completion (estimated November 2026). Brief summary: This is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device, a CE-certified (Class IIb, MDR) device that monitors left ventricular filling pressures in heart failure patients. The algorithm will be validated through internal cross-validation, external validation against an independent cohort with paired PPG-ECG recordings, and validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.